IKARIA: Advancing Critical Care
  • About Us
    • Our Company
    • Our Leadership
    • News
    • Partners
  • Our Science
  • INOtherapy
  • NICU Parent Information
  • Lucassin
  • Contact Us

Ikaria News

Lucassin launches in Australia

April 23, 2012 Read More

Ikaria Appoints Chief Medical Officer

April 11, 2012 Read More

FDA Clears Expanded Compatibility for INOMAX Drug Delivery Systems

March 23, 2012 Read More

FDA Grants Orphan Drug Designation to Ikaria for use of Inhaled Nitric Oxide in Pulmonary Artery Hypertension

January 23, 2012 Read More

Ikaria Commences Global Registration Trial for Bioabsorbable Cardiac Matrix PRESERVATION I Investigates Novel Device for Cardiac Remodelling and Congestive Heart Failure

January 4, 2012 Read More

Ikaria Names New Chief Financial Officer

October 11, 2011 Read More

Ikaria Launches Next-Generation Drug-Delivery System in USA

April 11, 2011 Read More

Ikaria Introduces Next-Generation INOMAX® Drug-Delivery System in Australia

March 23, 2011 Read More

FDA Extends Marketing Exclusivity For INOMAX®

January 5, 2011 Read More

Ikaria Begins Enrollment of Pivotal Trial For Lucassin®

November 30, 2010 Read More
  • Home
  • Terms of Use
  • ikaria.com (US)
Copyright © 2013 Ikaria Australia. All rights reserved.
The product information presented here is intended for use in Australia.